The AAMDSIF Leadership in Science Award was presented to Guillermo Garcia-Manero at the 9th International
Bone Marrow Failure
Bone Marrow Failure:
A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be…
Disease Scientific Symposium in March 2024. Dr. Garcia-Manero is a professor in the Department of Leukemia, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center and Chair of the Section of
Myelodysplastic Syndromes
Myelodysplastic Syndromes:
(my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People with MDS have low blood cell count for at…
. His research focuses on improving outcomes and quality of life of patients with leukemia and MDS by studying the molecular basis of these diseases and by developing new therapeutic alternatives for patients.
Dr. Garcia-Manero also directs the MDS/AML Moon Shot program at MD Anderson, which is designed to greatly accelerate the pace of scientific discoveries and the transition of new therapeutics to the clinic. The Moon Shot program has resulted in over 500 publications in the areas of biology, therapy and prognostication of these disorders and the development of multiple
clinical trials
clinical trials:
Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study.
Understanding Clinical Trials
Clinical…
.
Dr. Garcia-Manero has presented at numerous professional education and patient education programs for AAMDSIF and he has been a member of our Medical Advisory Board since 2007.